Last year, we reported on AstraZeneca's decision to appeal to the European Court of Justice (ECJ) against a finding by the ...
Case C-130/11 Neurim Pharmaceuticals
In Neurim the UK court is seeking additional clarification from the European Court of ...
Novartis announced on Tuesday that it is seeking a judicial review of a decision made by four NHS Primary Care Trusts to approve ...
Cross border injunctions possible in patent cases says Advocate General
C 616/10 Solvay SA v Honeywell Fluorine Products ...
Welcome to the January issue of InFocus, our life sciences and healthcare e-newsletter. In this issue we look at: ...
The Government announced in its Autumn Statement in November 2011 that it would consult on the introduction of an 'above the ...
There have been no developments of any significance towards finalising agreement on the "EU patent package” (unitary patent, ...
A recent ruling by the Prescription Medicines Code of Practice Authority (the “PMCPA”) has illustrated the challenges that ...
Taylor Wessing has won the European Life Sciences IP Firm of the Year 2012 at the Managing Intellectual Property Global Awards ...
Usage patents, carve-outs, skinny labelling and off-label prescribing
The competitive environment in which life sciences ...
Mr. Justice Arnold handed down judgment of the UK High Court today declaring patent EP (UK) 0 907 364 invalid for obviousness. ...
Welcome to the January issue of InFocus, our life sciences and healthcare e-newsletter. In this issue we look at: ...
The latest news is that the so-called Warsaw Convention was not signed on 22 December. According to the press release from ...
As ever, contractual disputes have kept the English courts busy in 2011. Here is a quick roundup of some of the ...
2011 was a year in which the UK life sciences industry has had much to consider: the NHS reforms, the Government’s Strategy for ...
There has been a multitude of references to the European Court of Justice (ECJ) to determine how and under what conditions, SPCs ...
On 6 December 2011, the Government published draft legislation for consultation on the proposed full reform to the controlled ...
We have followed the development and reported on proposals for amendments to EU legislation relating to prescription-only ...
Merck & Co. Inc. v Deutsches Patent- und Markenamt (Case C-125/10)
ECJ decide on negative / zero term SPCs and the starting ...
Following close behind last week’s Autumn Statement by the Chancellor, the Government has today published draft legislation ...
Autumn Statement update
Following the consultation over the summer on Venture Capital Schemes, the Chancellor announced the ...
In the October issue of our life sciences and healthcare eBulletin, InFocus, we set out the background and discussed Advocate ...
HM Treasury is expected to publish draft legislation on 6th December 2011, covering both the Patent Box and the R&D tax ...
Welcome to the October issue of InFocus, our life sciences and healthcare e-newsletter. In this issue we look ...
Unitary Patent
As we reported in the July InFocus draft regulations were published on the establishment of a unitary European ...
Today the CJEU gave judgment in the Synthon v Merz preliminary reference (C-195/09). This was a reference from the UK High Court ...
In its 2011 Budget, the Government announced a substantial increase in the tax relief available under the Enterprise Investment ...
As previously reported in our e-newsletters, InFocus - January 2011 and InFocus - October 2010, there have been a number of ...
Welcome to the July issue of InFocus, our life sciences and healthcare e-newsletter. In this issue we look at: ...
Social media channels are the latest and most dynamic and interactive marketing tools available to business, but in the UK most ...
Merck & Co Inc v Deutsches Patent- und Markenamt (Case C-125/10)
In his opinion on 9 June 2011, Advocate General Yves Bot ...
In its Plan for Growth published in March, the UK Government committed to ensure that the intellectual property system in the UK ...
Following the publication by the Commission of the draft regulations necessary to implement unitary patent protection on 13 April ...
Improved healthcare means opportunities for life sciences and healthcare companies
Successive UK governments have recognised ...
At a time when the value of emerging markets to the pharmaceutical industry is increasing, the global reach of the Bribery Act ...
Welcome to the April issue of InFocus, our life sciences and healthcare e-newsletter. In this issue we look at: ...
The Prescription Medicines Code of Practice Authority (PMCPA) has issued informal guidance on the use of digital communications ...
At a time when industry experts are talking about the death of the blockbuster drug, product lifecycle management strategies are ...
In yesterday's Budget, the Chancellor announced a raft of measures to boost corporate business in the UK. From a small and medium ...
As we reported in the January issue of InFocus the long anticipated document entitled “Corporate Tax Reform” was published by the ...
11-Jan-2011 |
Competition, EU and Trade,
Copyright & Media Law,
Corporate,
Employment & Pensions,
IT & Telecoms,
Life Sciences & Healthcare,
Patents,
Pharmaceutical Law,
Technology, Media & Telecoms,
Trade Marks & DesignsWelcome to the January 2011 edition of InFocus, the Life Sciences and Healthcare newsletter.
This month we discuss:
Sold Out - ...
The New Research & Development and Specialisation Block Exemption Regulations and Horizontal Co-Operation Agreements ...
2010 was the year in which the FDA had said they would issue some guidance on the use of social media by pharma. It was ...
The European Commission has escalated its crackdown on the pharma sector, conducting dawn raids yesterday on the originator ...
Welcome to the October 2010 edition of InFocus, the Life Sciences and Healthcare newsletter.
This month we discuss:
Developing ...
Rising pressure to find new products is prompting big pharmaceutical companies to license or acquire biotechnology companies' ...
In the July issue of InFocus we discuss:
Centralised procedure: guidance on duplicate marketing authorisations KREMEZIN and ...
The venture capital and life sciences groups at industry leading law firm, Taylor Wessing LLP, have advised new client, Seroba ...
EU moves closer to Biosimilar antibodies
Welcome to the October 2009 issue of InFocus
Happy New Year and welcome to the January 2009 issue of InFocus. If you have any comments on the contents or the format please ...
Taylor Wessing's Life Sciences & Healthcare Group has advised Innate Pharma (IPH) on an agreement with Novo Nordisk, in which ...
